Form 4: BeOne Medicines Director Gifts Shares

BeOne Medicines Director and Scientific Advisory Board Chair, Xiaodong Wang, gifted 424,073 ordinary shares, reducing direct beneficial ownership.

Summary

• Wang Xiaodong, a Director, 10% Owner, and Chair of the Scientific Advisory Board of BeOne Medicines Ltd. (ONC), reported a transaction.
• On November 7, 2025, Wang Xiaodong made a bona fide gift of 424,073 ordinary shares.
• Following this transaction, Wang Xiaodong directly beneficially owns 4,582,601 ordinary shares.
• Indirect beneficial ownership includes 1,025,063 ordinary shares held by a family trust, 3,953,100 ordinary shares held by Wang Investment LLC, and 50 ordinary shares held by the spouse of the Reporting Person.
• Wang Xiaodong disclaims beneficial ownership for the shares held by the family trust and Wang Investment LLC.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (a gift of shares) by a director, which is a standard disclosure and does not inherently indicate a positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Director Wang Xiaodong gifted 424,073 ordinary shares.

Key Dates

Recommendation

The filing details a routine insider gift of shares, which is a standard disclosure and does not provide new information that would fundamentally alter the investment thesis for BeOne Medicines Ltd. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive operational or financial updates.

Keywords

BeOne Medicines, ONC, Form 4, Insider Transaction, Share Gift, Beneficial Ownership, Xiaodong Wang, Director, 10% Owner, Scientific Advisory Board